Avanos Medical, Inc.
AVNSDelisted- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001606498
Avanos Medical, Inc. was delisted in 2026; its insiders filed their last Form 4 on Jul 28, 2026; 286 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 286
- Q2 2026, +30 vs. previous quarter
- 13F value
- $1.08B
- Reported value at the end of Q2 2026
- Superinvestors holding
- 0
- At the end of Q2 2026
Superinvestors holding AVNS, Q2 2026
No superinvestor reported holding AVNS at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Avanos Medical, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2025 (view filing) | Nov 18 | 1 day | Holbrook KerrSVP, Chief Commercial Officer | SSale | −15.0K | $11.00 | −$165.0K | −15.2%83.9K after | 4 lots |
| Aug 15, 2025 (view filing) | Aug 13 | 2 days | Blackford GaryDirector | PPurchase | +20.0K | $10.98 | +$219.6K | +27.9%91.6K after | |
| Aug 15, 2025 (view filing) | Aug 13 | 2 days | Blackford GaryDirector | PPurchase | +40.0K | $11.00 | +$440.0K | New position40.0K after | |
| Mar 10, 2025 (view filing) | Mar 6 | 4 days | Holbrook KerrSVP, Chief Commercial Officer | SSale | −7.00K | $15.25 | −$106.8K | −7.9%82.0K after | |
| Mar 15, 2024 (view filing) | Mar 14 | 1 day | Greiner MichaelSVP - Chief Financial Officer | SSale | −8.00K | $19.12 | −$153.0K | −5.0%151.5K after | 6 lots |
| Mar 11, 2024 (view filing) | Mar 11 | Same day | Shimer Julie AnnDirector | PPurchase | +500 | $19.85 | +$9.93K | +1.0%50.1K after | |
| Sep 16, 2021 (view filing) | Sep 15 | 1 day | Oleary Patrick JDirector | PPurchase | +5.00K | $31.63 | +$158.1K | +17.3%33.9K after | 4 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Avanos Medical, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7,468,794 | $185.8M | 0.00% | +625,061+9.1% | Added |
| Highland Capital Management Fund Advisors, L.P. | 2,177,366 | $54.2M | 3.62% | +2,177,366 | New |
| State Street Corp | 2,010,691 | $50.0M | 0.00% | +38,168+1.9% | Added |
| Vanguard Capital Management LLC | 1,993,794 | $49.6M | 0.00% | +21,829+1.1% | Added |
| TIG Advisors, LLC | 1,668,329 | $41.5M | 1.91% | +1,668,329 | New |
| Millennium Management LLC | 1,524,553 | $37.9M | 0.03% | +1,510,727+10,926.7% | Added |
| Vivaldi Asset Management, LLC | 1,184,190 | $29.5M | 1.72% | +1,184,190 | New |
| Geode Capital Management, LLC | 1,181,164 | $29.4M | 0.00% | +86,929+7.9% | Added |
| JPMorgan Chase & Co | 1,099,770 | $27.4M | 0.00% | +848,608+337.9% | Added |
| Charles Schwab Investment Management Inc | 946,344 | $23.5M | 0.00% | −111,722−10.6% | Reduced |